Zentalis Pharmaceuticals (ZNTL) just unveiled an update.
Melissa Epperly has stepped down as CFO and other key financial roles at Zentalis Pharmaceuticals, with a search for her replacement underway. In the interim, President Cam Gallagher takes over as CFO, bringing extensive leadership experience from previous biotech ventures and board positions. Meanwhile, Vincent Vultaggio steps in as the principal accounting officer, leveraging his two decades of finance expertise. Both appointments aim to maintain Zentalis’s financial stability during this transition.
Find detailed analytics on ZNTL stock on TipRanks’ Stock Analysis page.
